Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Experimental Hematology
|
May 1, 1995
Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors
S D Gore, S Amin, L J Weng, et al.
Journal of Immunological Methods
|
September 14, 1990
Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry
S D Gore, M B Kastan, S N Goodman, et al.
Leukemia
|
April 1, 1992
Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells
C A Hurwitz, S D Gore, K D Stone, et al.
Endocrinology
|
January 1, 1982
Antagonistic interactions of adenosine and prostaglandin F2 alpha modulate acute responses of luteal cells to luteinizing hormone
H R Behrman, A K Hall, S L Preston, et al.
Leukemia & Lymphoma
|
September 1, 1996
Addition of etoposide to initial therapy of adult acute lymphoblastic leukemia: a combined clinical and laboratory study
S H Kaufmann, J E Karp, P J Burke, et al.
In Vivo (Athens, Greece)
|
April 28, 1999
Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1
J A DiGiuseppe, M B Kastan, L J Weng, et al.
Molecular and Cellular Endocrinology
|
December 1, 1983
Inhibitory characteristics of prostaglandin F2 alpha in the rat luteal cell
L J Dorflinger, J L Luborsky, S D Gore, et al.
The Journal of the Association of Physicians of India
|
August 17, 2006
Study of inheritance of diabetes mellitus in Western Indian population by pedigree analysis
Sonali S Deo, S D Gore, D N Deobagkar, et al.
Leukemia
|
August 18, 1999
Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoic acid
K H Yu, L J Weng, S Fu, et al.
Leukemia
|
March 1, 1994
Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery
S D Gore, A D Donnenberg, B A Zehnbauer, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Experimental Hematology
|
May 1, 1995
Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors
S D Gore, S Amin, L J Weng, et al.
Journal of Immunological Methods
|
September 14, 1990
Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry
S D Gore, M B Kastan, S N Goodman, et al.
Leukemia
|
April 1, 1992
Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells
C A Hurwitz, S D Gore, K D Stone, et al.
Endocrinology
|
January 1, 1982
Antagonistic interactions of adenosine and prostaglandin F2 alpha modulate acute responses of luteal cells to luteinizing hormone
H R Behrman, A K Hall, S L Preston, et al.
Leukemia & Lymphoma
|
September 1, 1996
Addition of etoposide to initial therapy of adult acute lymphoblastic leukemia: a combined clinical and laboratory study
S H Kaufmann, J E Karp, P J Burke, et al.
In Vivo (Athens, Greece)
|
April 28, 1999
Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1
J A DiGiuseppe, M B Kastan, L J Weng, et al.
Molecular and Cellular Endocrinology
|
December 1, 1983
Inhibitory characteristics of prostaglandin F2 alpha in the rat luteal cell
L J Dorflinger, J L Luborsky, S D Gore, et al.
The Journal of the Association of Physicians of India
|
August 17, 2006
Study of inheritance of diabetes mellitus in Western Indian population by pedigree analysis
Sonali S Deo, S D Gore, D N Deobagkar, et al.
Leukemia
|
August 18, 1999
Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoic acid
K H Yu, L J Weng, S Fu, et al.
Leukemia
|
March 1, 1994
Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery
S D Gore, A D Donnenberg, B A Zehnbauer, et al.
Page
of 5